Herein, we deployed this technology against a colon cancer cell line; however, our additional work shows that the same approach is valid for a very different A172 glioblastoma brain tumor cell line when an anti-IL13 was used as an anchoring antibody instead of C225. Here, IL13 is linked to colonic neoplasm.